Home / Events / Payer Predictions: Evolution of the U.S. Digital Therapeutics Reimbursement Landscape


Payer Predictions: Evolution of the U.S. Digital Therapeutics Reimbursement Landscape

Available On Demand

The digital therapeutics (DTx) market is growing rapidly, but a lack of clarity around their reimbursement framework in the U.S. means that there is limited coverage. DTx developers— and pharmaceutical organizations seeking an integrated digital offering— are left to wonder how the payer landscape will evolve as they strategize for the future.

Join Trinity Life Sciences’ MedTech and Evidence, Value, Access and Pricing experts as they explore what the future DTx reimbursement landscape might look like, drawing upon detailed first-hand insights from medical and pharmacy directors at large U.S. payer organizations.

Key Webinar Topics:

  • Overview of DTx and the current reimbursement landscape in the U.S.
  • Case Study: How a DTx developer is navigating the challenges of commercializing prescription DTx – what level of evidence is good enough?
  • Payer predictions about the evolution of DTx coverage
  • Implications for DTx developers, pharmaceutical manufacturers, providers and patients


Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.